Lemonaid Health vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Lemonaid Health overall, scoring 7.7/10 vs 7.2/10. MEDVi is more affordable at $299/mo vs $348/mo. Choose Lemonaid Health for users who want glp-1 access from an established, trusted tel. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Lemonaid Health and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Lemonaid Health
#37 of 40Well-known telehealth platform (acquired by 23andMe) offering compounded GLP-1 medications with a focus on medical credibility and established trust.
Visit Lemonaid HealthMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Lemonaid Health | MEDVi |
|---|---|---|
| Our Score | 7.2/10 | 7.7/10 |
| Starting Price | $348/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want GLP-1 access from an established, trusted telehealth platform | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #37 | #21 |
Pros & Cons Compared
Lemonaid Health
Pros
- +Established telehealth brand operating since 2013 — one of the longest track records in the industry
- +Strong medical credibility with board-certified physicians and rigorous prescribing standards
- +Clean, straightforward onboarding process with detailed medical intake
- +Responsive support team with phone, chat, and email options during extended hours
Cons
- −$229/mo for compounded-only is above average — competitors offer similar products for $120-180/mo
- −No brand-name GLP-1 options through their program
- −No insurance billing for GLP-1 medications
- −The 23andMe acquisition created some uncertainty about the platform's long-term focus
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Lemonaid Health with a score of 7.7/10 vs 7.2/10. If budget is your priority, MEDVi starts at $299/mo compared to Lemonaid Health's $348/mo. Choose Lemonaid Health if you want: users who want glp-1 access from an established, trusted telehealth platform. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.